Skip to main content
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)
  • EN
  • FR
  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • COVID-19 Pandemic Resources
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
  • Archived Documents
  • Links & Resources
  • Citations
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

Main navigation

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • COVID-19 Pandemic Resources
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
  • Archived Documents
  • Links & Resources
  • Citations
  • EN
  • FR

Breadcrumb

  • Home
  • Guidelines & Recomme...
  • Current: Adverse Event Recommendations

Adverse Event Recommendations

This section is dedicated to recommendations around adverse events resulting from blood component / product transfusion, including recalling samples based on post-donation recipient information and the adverse event reporting pathway.
Canadian Transfusion Adverse Event Reporting Form
Download PDF (441.83 KB)
Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada - Supplement: Contacts for National ATR Report Recipients and Provincial TTISS Personnel
Download PDF (357.8 KB)
Copy citation
Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada: a NAC and Québec Hemovigilance System Collaborative Initiative
Download PDF (2.05 MB)
Copy citation
Recommendations for the Notification of Recipients of a Blood Component Recall
Download PDF (1.21 MB)
Copy citation
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

NAC

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
  • Archived Documents
  • Links & Resources
  • Citations

Recently updated resources

  • NAC Recommendations for the Use of Solvent-Detergent Plasma in Canada
  • NAC Position Paper: Utilization and Inventory Management of Group O RH(D)- Negative Red Cells
  • Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada: a NAC and Québec Hemovigilance System Collaborative Initiative
  • NAC Statement on Recombinant Factor VIIa
  • NAC Statement on Factor XIII Concentrate Use

Contact

NAC Chair

Andrew Shih

NAC Project Coordinator

Kendra Stuart

NationalBloodPortfolio@gov.bc.ca

© Copyright 2024. National Advisory Committee on Blood and Blood Products. All rights reserved. Disclaimer & Privacy Info